Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40001278
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
30/06/2022
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target Illumina, Inc. commits to reach net zero greenhouse gas emissions across direct operations and the value chain by 2050 from a 2019 base year. Near-Term Targets Illumina, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 46% by 2030 from a 2019 base year. Illumina, Inc. also commits to increase annual sourcing of renewable electricity from 0.6% in 2019 to 100% by 2030. Illumina, Inc. further commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, upstream transportation and distribution, business travel, employee commuting and investments 46% by 2030 from a 2019 base year. Long-Term Targets Illumina, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2019 base year. Illumina, Inc. commits to reduce absolute scope 3 emissions from purchased goods and services, capital goods, upstream transportation and distribution, business travel, employee commuting and investments 90% by 2050 from a 2019 base year.
Statut
Targets setAnnée cible
2050
Statut
BA1.5 memberDate d'engagement
12/08/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
US4523271090
LEI
SQ95QG8SR5Q56LSNF682
Source : Science Based Targets initiative | Données publiques